Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Lind

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Plos One|August 26, 2021
Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort studyArne Søraas, Karl Trygve Kalleberg, John Arne Dahl, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 17, 2021
Rapid SARS-CoV-2 variant monitoring using PCR confirmed by whole genome sequencing in a high-volume diagnostic laboratoryAndreas Lind, Regine Barlinn, Elisabeth Toverud Landaas, et al.
Viruses|November 11, 2022
Omicron Variant Generates a Higher and More Sustained Viral Load in Nasopharynx and Saliva Than the Delta Variant of SARS-CoV-2Beathe K Granerud, Thor Ueland, Andreas Lind, et al.
Health Science Reports|January 25, 2021
Severe acute respiratory syndrome coronavirus 2 prevalence in 1170 asymptomatic Norwegian conscriptsEinar Kristian Borud, Espen Rostrup Nakstad, Siri Eldevik Håberg, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 17, 2021
Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021Lin T Brandal, Emily MacDonald, Lamprini Veneti, et al.
Frontiers in Immunology|July 28, 2023
Robust spike-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort studyLorenzo Federico, Tor Henrik Anderson Tvedt, Murat Gainullin, et al.
Scientific Reports|December 11, 2020
Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19Marthe Jøntvedt Jørgensen, Jan Cato Holter, Erik Egeland Christensen, et al.
Journal of Internal Medicine|September 18, 2023
Circulating markers of extracellular matrix remodelling in severe COVID-19 patientsSarah Louise Murphy, Bente Halvorsen, Jan Cato Holter, et al.
The Lancet Regional Health. Europe|December 3, 2024
Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort studyHilde S Ørbo, Taissa de Matos Kasahara, Asia-Sophia Wolf, et al.
The Journal of Allergy and Clinical Immunology|September 24, 2020
Elevated plasma sTIM-3 levels in patients with severe COVID-19Thor Ueland, Lars Heggelund, Andreas Lind, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Plos One|August 26, 2021
Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort studyArne Søraas, Karl Trygve Kalleberg, John Arne Dahl, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 17, 2021
Rapid SARS-CoV-2 variant monitoring using PCR confirmed by whole genome sequencing in a high-volume diagnostic laboratoryAndreas Lind, Regine Barlinn, Elisabeth Toverud Landaas, et al.
Viruses|November 11, 2022
Omicron Variant Generates a Higher and More Sustained Viral Load in Nasopharynx and Saliva Than the Delta Variant of SARS-CoV-2Beathe K Granerud, Thor Ueland, Andreas Lind, et al.
Health Science Reports|January 25, 2021
Severe acute respiratory syndrome coronavirus 2 prevalence in 1170 asymptomatic Norwegian conscriptsEinar Kristian Borud, Espen Rostrup Nakstad, Siri Eldevik Håberg, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 17, 2021
Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021Lin T Brandal, Emily MacDonald, Lamprini Veneti, et al.
Frontiers in Immunology|July 28, 2023
Robust spike-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort studyLorenzo Federico, Tor Henrik Anderson Tvedt, Murat Gainullin, et al.
Scientific Reports|December 11, 2020
Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19Marthe Jøntvedt Jørgensen, Jan Cato Holter, Erik Egeland Christensen, et al.
Journal of Internal Medicine|September 18, 2023
Circulating markers of extracellular matrix remodelling in severe COVID-19 patientsSarah Louise Murphy, Bente Halvorsen, Jan Cato Holter, et al.
The Lancet Regional Health. Europe|December 3, 2024
Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort studyHilde S Ørbo, Taissa de Matos Kasahara, Asia-Sophia Wolf, et al.
The Journal of Allergy and Clinical Immunology|September 24, 2020
Elevated plasma sTIM-3 levels in patients with severe COVID-19Thor Ueland, Lars Heggelund, Andreas Lind, et al.
Pageof 5